Pfizer and Moderna executives said the companies are increasing their coronavirus vaccine supplies and are expected to double and potentially triple shipments in the coming weeks. This emerges from the statements published by Congress on Monday.
In a prepared statement to be made before a House subcommittee on Tuesday, John Young, Pfizer’s chief business officer, is expected to say the company plans to increase its delivery capacity from 4 to 5 million cans a week to more by mid-mid than 13 million raise in March.
According to Dr. Stephen Hoge, the company’s president, expects Moderna to double its monthly delivery capacity to 40 million cans by April. Moderna has dispensed 45 million cans so far, says Hoge.
Young attributed the increased supply to “significant investments” by Pfizer in multiple manufacturing facilities and other improvements.
The US has exceeded 500,000 coronavirus deaths and equity issues persist in the distribution of vaccines. The Biden government said this month it is increasing supplies to low-income communities and people of color who have been hard hit by the virus.
The Food and Drug Administration last year approved emergency use of vaccines that use mRNA and are more than 90 percent effective after two doses.